Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Dow
Cipla
Covington
Novartis
Baxter
Medtronic
Express Scripts
Chinese Patent Office
Mallinckrodt

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020411

« Back to Dashboard

NDA 020411 describes CERVIDIL, which is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. Additional details are available on the CERVIDIL profile page.

The generic ingredient in CERVIDIL is dinoprostone. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dinoprostone profile page.
Summary for 020411
Tradename:CERVIDIL
Applicant:Ferring Pharms Inc
Ingredient:dinoprostone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
Formulation / Manufacturing:see details
Pharmacology for NDA: 020411
Ingredient-typeProstaglandins
Medical Subject Heading (MeSH) Categories for 020411
Suppliers and Packaging for NDA: 020411
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CERVIDIL dinoprostone INSERT, EXTENDED RELEASE;VAGINAL 020411 NDA Ferring Pharmaceuticals Inc. 55566-2800 N 55566-2800-1
CERVIDIL dinoprostone INSERT, EXTENDED RELEASE;VAGINAL 020411 NDA Ferring Pharmaceuticals Inc. 55566-9500 N 55566-9500-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INSERT, EXTENDED RELEASE;VAGINALStrength10MG
Approval Date:Mar 30, 1995TE:RLD:Yes

Expired US Patents for NDA 020411

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ferring Pharms Inc CERVIDIL dinoprostone INSERT, EXTENDED RELEASE;VAGINAL 020411-001 Mar 30, 1995 ➤ Sign Up ➤ Sign Up
Ferring Pharms Inc CERVIDIL dinoprostone INSERT, EXTENDED RELEASE;VAGINAL 020411-001 Mar 30, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Department of Justice
Citi
Accenture
Chinese Patent Office
Covington
McKinsey
Cerilliant
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot